While there have been many significant advances in healthcare in the past 25 years, including new treatments for cancer ...

Sonnet BioTherapeutics (SONN) announced an expansion of its Phase 1 SB101 clinical study of SON-1010 in adult patients with advanced solid ...

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced ...

The Arkansas Integrative Metabolic Research Center will host Jeffrey Rathmell, a professor of pathology, microbiology and immunology from Vanderbilt University on Wednesday, Jan. 22.

The following is a summary of “Role of T cell metabolism in brain tumor development: a genetic and metabolic approach,” ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Objectives SLE is a multifaceted autoimmune disorder with a complex pathogenesis involving genetic, environmental and ...

Immunotherapy, cancer treatments that alter the immune system, making it better apt to fight tumor cells, have provided novel ...

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme—P4HA1 prolyl hydroxylase, ...

The tissue adjacent to a tumor behaves differently than areas farther away: The tumor's cancerous cells influence their surroundings, blocking the body's immune defenses and creating a sort of haven ...

Scientists from A*STAR Genome Institute of Singapore (A*STAR GIS) have uncovered that a key enzyme – P4HA1 prolyl hydroxylase ...

The tissue adjacent to a tumor behaves differently than areas farther away. The tumor's cancerous cells influence their ...